Daily cotadutide administration also reduced body weight by up to 11% in normal weight cynomolgus monkeys over 8 weeks [41]
It helps control your blood sugar and reduces your appetite, so you feel satisfied while eating smaller portions
Waist measurement beats scale weight
As a part of our process, you will need to complete an online health screening with our telehealth providers to ultimately determine whether you are eligible to be prescribed compounded GLP-1/GIP injections
Key Takeaways Retatrutide targets three hormones (GLP-1, GIP, glucagon), tirzepatide targets two (GLP-1, GIP), and semaglutide targets one (GLP-1) At 68 weeks, retatrutide achieved 28.7% average weight loss, tirzepatide approximately 22%, and semaglutide around 17% on the highest doses Side effects are similar across all three medications, mainly digestive issues like nausea and diarrhoea Retatrutide is not yet approved and won't be available until mid-2026 at the earliest Retatrutide is not yet approved and is not currently available in the UK Tirzepatide (Mounjaro) and semaglutide (Wegovy) are both available now in the UK through NHS or private providers By entering I agree to the Terms and Conditions
